RMHB Rocky Mountain High Brands, Inc.

Charting New Waters at Tampa General Out here in the blue, the tides of healthcare can swell mighty quick. That's where Tampa General Hospital keeps its anchor firm, announcing Lijah Lokenauth's leap to Executive VP and CFO. If you ask me, it's all about keeping the ship steady—this fella's been steering their financial boat through some hefty waves since 2018....

Thirty Years of Empowering Athletes In the world of adaptive sports, every slam dunk and sprint finish means more than just a win; it signifies victory over barriers that many of us can't even fathom. That's the world BlazeSports America has championed for three decades now. And let me tell you, not every organization has what it takes to stick it out this long,...

Hims & Hers Under Fire: Act Now or Pay Later If you're holding $HIMS shares, let me tell you—this isn't the time to snooze. With a federal lawsuit breathing down its neck, Hims & Hers Health, Inc. finds itself teetering on the precipice of serious financial and legal mayhem. The clock's ticking with the class action cutoff looming on November 2, 2026. If you're nursing...

New hires in biotech often get more than just a desk and a computer—they might just snag a piece of the company pie, too. Actinium Pharmaceuticals, the folks dabbling in the mysterious world of targeted radiotherapies, pulled a classic move in welcoming a fresh face to their roster. On October 26, 2026, they rolled out an inducement stock option, a juicy carrot to lure...

Rethinking the Anti-TIGIT Game with HCB303 There's a fresh breeze blowing in the realm of immunotherapy, and it comes courtesy of HanchorBio's innovative trispecific approach. Now, for those of us who've been unimpressed by the underwhelming returns from anti-TIGIT trials, this new development might just stir the pot. HanchorBio's got the green light not only from the...

Humble Bundle Lends a Hand to Kidney Health There's something heartening in the way gaming and charity collide, especially when it comes down in favor of public health. Humble Bundle's latest charitable endeavor, the "Phunkier Physics" bundle, ropes in funds to battle kidney disease, a villain in its own right that affects millions. The initiative runs till November 13,...

The Fluence Fiasco: From Optimism to Legal Battles One minute you're riding high on promises, the next you're grappling with losses that could sink a ship. Fluence Energy (NASDAQ: FLNC) is learning this harsh lesson, as its shareholders eye a nasty $3 billion nosedive and a fresh securities class action lawsuit to boot. Imagine thinking you're poised to tap into an...

Riding the Revenue Wave Now we're talking about a bank knowing their business—InsCorp, Inc. recently flaunted a 12% year-on-year revenue bump for 3Q26, a testament to a strategy that's clearly sticking. Still, while those numbers are nice and shiny, the detailed breakdown shows earnings per share (EPS) barely budged from last quarter, coming in at $0.73, just a hair...

Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...

Brewers: Finally on Top of the World Boy oh boy, the Milwaukee Brewers have finally done it! After years of being the underdogs, the team has clinched their first-ever World Series championship in 2026. You think you're dreaming, but no, it's the real deal. The Brewers, once just a hopeful name on the roster of Major League Baseball's teams, have stormed their way to a...

Why JD.Com's Stock Is Experiencing Remarkable Growth JD.Com Inc shares have gained significant momentum, rising by 27% over the past week. The e-commerce giant is witnessing a notable uptrend, reflecting a broader rally observed among U.S.-listed Chinese companies as they benefit from renewed market optimism. Key Factors Behind the Surge The primary driver of JD.com’s...

VivoPower got tangled up in the market when it wrapped up a stock offering, closing just after the bell on a Monday, pushing out 3.2 million ordinary shares to institutional players. That raised about $4 million in gross proceeds, but you gotta wonder: is this really enough to fix their woes? Debt Reduction vs. Inventory Needs: VivoPower’s Tightrope Walk The cash from...

Vital Farms Investor Conferences Notification Vital Farms (Nasdaq: VITL), known for its commitment to bringing ethically produced foods to the market, has officially announced its participation in an exciting series of investor conferences scheduled for June 2025. As a Certified B Corporation, Vital Farms stands out for its dedication to sustainable farming and the humane...

Sigma Lithium: Preparing to Unveil Q3 2024 Results Sigma Lithium Corporation (NASDAQ: SGML) is gearing up to share its financial results for the third quarter, marking a significant moment in the company's journey. This eagerly awaited announcement will come before the market opens, and the commitment to transparency and information-sharing reflects Sigma's dedication to...

Electric Mobility Takes Center Stage The electric mobility scene is buzzing this weekend as GOTRAX straps on its helmet and rolls into the Electrify Expo's Demo Days at the iconic Rose Bowl Stadium in California. From June 27th to 28th, expect an electrifying showcase, where attendees can test ride some of the latest and greatest in electric scooters and bikes. GOTRAX is...